198 related articles for article (PubMed ID: 33688380)
1. The Value of a Seven-Autoantibody Panel Combined with the Mayo Model in the Differential Diagnosis of Pulmonary Nodules.
Ling Z; Chen J; Wen Z; Wei X; Su R; Tang Z; Hu Z
Dis Markers; 2021; 2021():6677823. PubMed ID: 33688380
[TBL] [Abstract][Full Text] [Related]
2. Comparative Study of Autoantibody Responses between Lung Adenocarcinoma and Benign Pulmonary Nodules.
Wang J; Shivakumar S; Barker K; Tang Y; Wallstrom G; Park JG; Tsay JC; Pass HI; Rom WN; LaBaer J; Qiu J
J Thorac Oncol; 2016 Mar; 11(3):334-45. PubMed ID: 26896032
[TBL] [Abstract][Full Text] [Related]
3. [Value of Combined Detection of Cytokines and Tumor Markers in the
Differential Diagnosis of Benign and Malignant Solitary Pulmonary Nodules].
Shi J; Liu X; Ming Z; Li W; Lv X; Yang X; Wang Y; Zhang M; Yang S
Zhongguo Fei Ai Za Zhi; 2021 Jun; 24(6):426-433. PubMed ID: 34157802
[TBL] [Abstract][Full Text] [Related]
4. Case study of an autoantibody panel for early detection of lung cancer and ground-glass nodules.
Huo Y; Guo Z; Gao X; Liu Z; Zhang R; Qin X
J Cancer Res Clin Oncol; 2020 Dec; 146(12):3349-3357. PubMed ID: 32648227
[TBL] [Abstract][Full Text] [Related]
5. The diagnostic value of a seven-autoantibody panel and a nomogram with a scoring table for predicting the risk of non-small-cell lung cancer.
Wang W; Zhuang R; Ma H; Fang L; Wang Z; Lv W; Hu J
Cancer Sci; 2020 May; 111(5):1699-1710. PubMed ID: 32108977
[TBL] [Abstract][Full Text] [Related]
6. Combining serum miRNAs, CEA, and CYFRA21-1 with imaging and clinical features to distinguish benign and malignant pulmonary nodules: a pilot study : Xianfeng Li et al.: Combining biomarker, imaging, and clinical features to distinguish pulmonary nodules.
Li X; Zhang Q; Jin X; Cao L
World J Surg Oncol; 2017 May; 15(1):107. PubMed ID: 28545454
[TBL] [Abstract][Full Text] [Related]
7. Significance of tumor-associated autoantibodies in the early diagnosis of lung cancer.
Du Q; Yu R; Wang H; Yan D; Yuan Q; Ma Y; Slamon D; Hou D; Wang H; Wang Q
Clin Respir J; 2018 Jun; 12(6):2020-2028. PubMed ID: 29356386
[TBL] [Abstract][Full Text] [Related]
8. The Combination of IgA and IgG autoantibodies against Transcriptional Intermediary Factor-1γ contributes to the early diagnosis of Lung Cancer.
Yu L; Lin X; Zhang L; Wu Q; Zhang S; Chen D; Pan X; Huang Y
Int J Med Sci; 2020; 17(11):1561-1568. PubMed ID: 32669959
[No Abstract] [Full Text] [Related]
9. Diagnostic value of circulating genetically abnormal cells to support computed tomography for benign and malignant pulmonary nodules.
Yang H; Chen H; Zhang G; Li H; Ni R; Yu Y; Zhang Y; Wu Y; Liu H
BMC Cancer; 2022 Apr; 22(1):382. PubMed ID: 35397524
[TBL] [Abstract][Full Text] [Related]
10. EarlyCDT®-Lung test: improved clinical utility through additional autoantibody assays.
Chapman CJ; Healey GF; Murray A; Boyle P; Robertson C; Peek LJ; Allen J; Thorpe AJ; Hamilton-Fairley G; Parsy-Kowalska CB; MacDonald IK; Jewell W; Maddison P; Robertson JF
Tumour Biol; 2012 Oct; 33(5):1319-26. PubMed ID: 22492236
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of a plasma biomarker panel for discerning clinical significance of indeterminate pulmonary nodules.
Daly S; Rinewalt D; Fhied C; Basu S; Mahon B; Liptay MJ; Hong E; Chmielewski G; Yoder MA; Shah PN; Edell ES; Maldonado F; Bungum AO; Borgia JA
J Thorac Oncol; 2013 Jan; 8(1):31-6. PubMed ID: 23201823
[TBL] [Abstract][Full Text] [Related]
12. Improving the efficiency of identifying malignant pulmonary nodules before surgery via a combination of artificial intelligence CT image recognition and serum autoantibodies.
Ding Y; Zhang J; Zhuang W; Gao Z; Kuang K; Tian D; Deng C; Wu H; Chen R; Lu G; Chen G; Mendogni P; Migliore M; Kang MW; Kanzaki R; Tang Y; Yang J; Shi Q; Qiao G
Eur Radiol; 2023 May; 33(5):3092-3102. PubMed ID: 36480027
[TBL] [Abstract][Full Text] [Related]
13. Plasma secretory phospholipase A2-IIa as a potential biomarker for lung cancer in patients with solitary pulmonary nodules.
Kupert E; Anderson M; Liu Y; Succop P; Levin L; Wang J; Wikenheiser-brokamp K; Chen P; Pinney SM; Macdonald T; Dong Z; Starnes S; Lu S
BMC Cancer; 2011 Dec; 11():513. PubMed ID: 22151235
[TBL] [Abstract][Full Text] [Related]
14. Early detection of lung cancer by using an autoantibody panel in Chinese population.
Ren S; Zhang S; Jiang T; He Y; Ma Z; Cai H; Xu X; Li Y; Cai W; Zhou J; Liu X; Hu X; Zhang J; Yu H; Zhou C; Hirsch FR
Oncoimmunology; 2018; 7(2):e1384108. PubMed ID: 29308305
[TBL] [Abstract][Full Text] [Related]
15. Autoantibody Signature Enhances the Positive Predictive Power of Computed Tomography and Nodule-Based Risk Models for Detection of Lung Cancer.
Massion PP; Healey GF; Peek LJ; Fredericks L; Sewell HF; Murray A; Robertson JF
J Thorac Oncol; 2017 Mar; 12(3):578-584. PubMed ID: 27615397
[TBL] [Abstract][Full Text] [Related]
16. Discovering Panel of Autoantibodies for Early Detection of Lung Cancer Based on Focused Protein Array.
Jiang D; Zhang X; Liu M; Wang Y; Wang T; Pei L; Wang P; Ye H; Shi J; Song C; Wang K; Wang X; Dai L; Zhang J
Front Immunol; 2021; 12():658922. PubMed ID: 33968062
[TBL] [Abstract][Full Text] [Related]
17. Tumor-derived Autoantibodies Identify Malignant Pulmonary Nodules.
Lastwika KJ; Kargl J; Zhang Y; Zhu X; Lo E; Shelley D; Ladd JJ; Wu W; Kinahan P; Pipavath SNJ; Randolph TW; Shipley M; Lampe PD; Houghton AM
Am J Respir Crit Care Med; 2019 May; 199(10):1257-1266. PubMed ID: 30422669
[No Abstract] [Full Text] [Related]
18. Evaluation of models for predicting the probability of malignancy in patients with pulmonary nodules.
Li Y; Hu H; Wu Z; Yan G; Wu T; Liu S; Chen W; Lu Z
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32068231
[TBL] [Abstract][Full Text] [Related]
19. Development of Diagnosis Model for Early Lung Nodules Based on a Seven Autoantibodies Panel and Imaging Features.
Xu L; Chang N; Yang T; Lang Y; Zhang Y; Che Y; Xi H; Zhang W; Song Q; Zhou Y; Yang X; Yang J; Qu S; Zhang J
Front Oncol; 2022; 12():883543. PubMed ID: 35530343
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis of lung cancer in individuals with solitary pulmonary nodules by plasma microRNA biomarkers.
Shen J; Liu Z; Todd NW; Zhang H; Liao J; Yu L; Guarnera MA; Li R; Cai L; Zhan M; Jiang F
BMC Cancer; 2011 Aug; 11():374. PubMed ID: 21864403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
